English

• Peganum harmala L. (Zygophyllaceae) is a perennial herb that is widely distributed in some arid and semi-arid areas of China, the United States, India, Iran, and Africa [1]. Its seeds are of high medicinal value and are often used to treat digestive cancers, colds, rheumatism, malaria, amnesia, and some skin diseases. The seeds are rich in alkaloids, mainly containing β-carbolines, followed by quinazolines. The compounds harmaline and harmine as β-carbolines constituted the main components of the seeds (Fig. 1) and the contents of these two alkaloids in the dried seeds were reported to be 5.6% and 4.3% (w/w) respectively [2]. Many dimeric alkaloids were isolated from Peganum harmala L. seeds with structures consisting of β-carboline polymerization, quinazoline polymerization, and polymerization of the above two, among others [3,4].

  Figure 1

  

  Figure 1.  Structure of compounds harmaline and harmine.

  DownLoad: Full-Size Img PowerPoint

  Over the years, the discovery of new alkaloids in Peganum harmala L. seeds has focused on the extraction and re-separation of the filtrate after alcohol extraction, acid solubilization, and alkali precipitation [5-13]. However, the precipitated fractions containing mainly harmaline and harmine after acid solubilization and base precipitation have hardly been isolated to explore new compounds. We have so far isolated 12 compounds from this precipitated fraction and a homologue of compound 3 (Fig. 2) has been published as a new compound [14]. This study also focused on this precipitation fraction and aimed to isolate new compounds from it, with their anticancer activities and related mechanisms being initially explored in vitro and in vivo.

  Figure 2

  

  Figure 2.  Structure and numbering of compounds 1–3.

  DownLoad: Full-Size Img PowerPoint

  Compound 1 was obtained as an orange amorphous powder. Its molecular formula was determined to be C₃₀H₃₁N₄⁺O₄Cl⁻ with 18 indices of hydrogen deficiency by high resolution electrospray ionization mass spectrometry (HR-ESI-MS) at m/z 511.2333 [M]⁺ (calcd. 511.2340). The compound displayed a distinct orange color under daylight in methanol indicating a large ultraviolet (UV) absorption and the presence of a very long conjugated structure. The UV spectra (Fig. S5 in Supporting information) of compound 1 displayed maximum UV absorption at λ_max 206, 334, and 466, verifying the above inferences. The data of ¹H nuclear magnetic resonance (NMR) (Table 1) combined with ¹H–¹H correlation spectroscopy (COSY) (Fig. 3) revealed the presence of two aromatic ABX spin systems (δ_H 7.64 (d, J = 8.7 Hz, 1H), 6.84 (dd, J = 8.7, 2.2 Hz, 1H), 6.96 (d, J = 2.2 Hz, 1H); 7.59 (d, J = 8.8 Hz, 1H), 6.82 (dd, J = 8.7, 2.2 Hz, 1H), 6.89 (d, J = 2.2 Hz, 1H)). The ¹H NMR data (Table 1) also showed the presence of three O-methyls (δ_H 3.83 (s, 3H), 3.84 (s, 3H), 3.63 (s, 3H)), one methyl (δ_H 2.87, (s, 3H)), one methylene (δ_H 4.66 (t, J = 7.3 Hz, 2H)), and two active hydrogens (δ_H 11.83 (N-H), 12.01 (N-H)), with N-H being assessed to be the indole N-H of β-carboline based on the structural features of the Peganum harmala L. alkaloids. The ¹³C NMR (Table 1) and distortionless enhancement by polarization transfer (DEPT) (Fig. S8 in Supporting information) data revealed the presence of four methylene carbons (δ_C 19.0, 25.9, 41.4, 48.8), combined with the heteronuclear single quantum correlation (HSQC) spectrum (Fig. S10 in Supporting information) to identify the hydrogens attached to them, of which three methylene hydrogens interfered with by water peaks were recognized (δ_H 3.26, 3.26, 3.32). The ¹H–¹H COSY (Fig. 3) relationship also displayed a coupling of methylene hydrogens (δ_H 4.66 (H-3) vs. 3.32 (H-4)) and there was also a coupling of δ_H 7.62 (H-3′) and δ_H 3.26 (H-2′). The carbon signal attached in δ_H 7.26 was not found in HSQC and this hydrogen was presumed to be an active hydrogen. The key heteronuclear multiple bond correlation (HMBC) cross-peaks (Fig. 3) showed that N-H at position 9′ correlated with C-10′, C-11′, C-12′, and C-13′ indicating the presence of indole ring of Part b (Fig. 2, compound 1). Similarly, the correlation of N-H at position 9 with C-10 and C-11 combined with the correlation of H-5 with C-11 suggested the presence of an indole ring in Part a (Fig. 2). The correlation of H-3 with C-18 could also be combined with the H-3 chemical shift (δ_H 4.66, δ_H-3 value that did not form N⁺ was generally < 4, e.g., harmaline (δ_H-3 3.67)) to indicate the formation of a 2-positioned N⁺. The HMBC correlation of H-3 with C-18 proved that the N atom at position 2 of the pyridine ring was connected to the other C atom, so the conclusions were consistent. In the case of the HMBC data both H-15 and H-17 correlated to C-10′, connecting Parts a and b. H-2′ (δ_H 7.62) was the N-H of the amide and generated a ¹H–¹H COSY correlation with H-3′ (δ_H 3.26), consistent with the structure as deduced. Additionally, the values of δ_H-3′ and δ_H-4′ were both 3.26. The HMBC spectrum (Fig. 3) displayed that methoxy H-20 (δ_H 3.63) was correlated with amide C-1′ (δ_C 157.3). By structural inference, compound 1 contained a long conjugated chain of the polymerized structure between harmaline (Part a) and ring-opened harmaline (Part b), with the latter being an analogous structure of pegaharmine E from a published article [11]. Since the total alkaloids were treated with hydrochloric acid after extraction and the NMR spectrum did not show any other anions containing carbon and hydrogen, as well as the fact that a saturated aqueous solution of the compound produced a white precipitate when titrated with silver nitrate solution, the anionic part was determined to be Cl⁻. The structural formula was shown in Fig. 2 and its solution could indeed display an orange color in daylight and a strong UV absorption at λ_max 466. The trivial name was given as peganumium A.

  Table 1

  

  Table 1.  ¹H and ¹³C NMR data of compounds 1–3 (ppm).

  DownLoad: CSV

  1 (600/150 MHz, DMSO–d6)				2 (600/150 MHz, DMSO–d6)				3 (400/100 MHz, CD3OD)
  No.	δH (J in Hz)	δC		No.	δH (J in Hz)	δC		No.	δH (J in Hz)	δC
  1		142.7 C		1		132.6 C		1		140.0 C
  2		N atom		2		N atom		2		N atom
  3	4.66 t (7.3)	48.8 CH2		3	4.92 t (7.2)	44.3 CH2		3	8.53 d (6.6)	134.5 CH
  4	3.32 overlap	19.0 CH2		4	3.26 overlap	19.1 CH2		4	8.34 d (6.6)	114.7 CH
  5	7.64 d (8.7)	120.6 CH		5	7.54 d (8.6)	120.1 CH		5	8.23 d (8.9)	125.5 CH
  6	6.84 dd (8.7, 2.2)	111.9 CH		6	6.77 dd (8.7, 2.2)	110.6 CH		6	7.06 dd (8.9, 2.2)	114.9 CH
  7		159.3 C		7		157.6 C		7		165.8 C
  8	6.96 d (2.2)	93.8 CH		8	6.92 d (2.2)	94.5 CH		8	7.17 d (2.2)	95.1 CH
  9	12.01	NH		9	11.78 s	NH		9a	14.10 s (CDCl3)	NH
  10		124.9 C		10		126.6 C		10		136.9 C
  11		117.6 C		11		112.9 C		11		134.7 C
  12		119.1 C		12		120.1 C		12		115.2 C
  13		140.8 C		13		139.2 C		13		148.5 C
  14	3.84 s	55.6 CH3		14	3.84 s	55.1 CH3		14	3.16 s	14.7 CH3
  15	8.36 s	113.2 CH		1′		141.6 C		15	6.03 s	87.2 CH2
  16		145.2 C		4′	7.20 s	104.9 CH		16	3.69 q (7.0)	66.8 CH2
  17	7.87 d (2.6)	119.1 CH		5′	7.94 d (8.6)	122.6 CH		17	1.24 t (7.0)	15.1 CH3
  18		154.0 C		6′	6.76 dd (8.6, 2.4)	107.6 CH		18	3.99 s	56.4 CH3
  19	2.87 s	21.1 CH3		7′		158.9 C
  20	3.63 s	51.4 CH3		8′	7.11 d (2.4)	100.1 CH
  1′		157.3 C		9′		N atom
  2′	7.62 m	NH		10′		152.8 C
  3′	3.26 overlap	41.4 CH2		11′		120.4 C
  4′	3.26 overlap	25.9 CH2		12′		117.6 C
  5′	7.59 d (8.8)	121.4 CH		13′		153.6 C
  6′	6.82 dd (8.7, 2.2)	111.4 CH		14′	3.85 s	55.3 CH3
  7′		158.8 CH		15′	2.84 s	19.6 CH3
  8′	6.89 d (2.2)	93.4 CH
  9′	11.83	NH
  10′		127.4 C
  11′		118.9 C
  12′		123.3 C
  13′		139.0 C
  14′	3.83 s	55.6 CH3
  a The chemical shift of the N-9 active hydrogen in CDCl3 was 14.10, while in DMSO–d6 it was 13.23.

  Figure 3

  

  Figure 3.  Key ¹H–¹H COSY and HMBC correlations of compounds 1–3.

  DownLoad: Full-Size Img PowerPoint

  Compound 2 was obtained also as a deep yellow amorphous powder. Its molecular formula was determined to be C₂₄H₂₁N₃O₂ with 16 indices of hydrogen deficiency by HR-ESI-MS at m/z 384.1699 [M + H]⁺ (calcd. 384.1707). The methanol solution of compound 2 was yellowish green in daylight and presumably, a long conjugate system was also present. The UV spectra (Fig. S13 in Supporting information) showed maximum UV absorption of compound 2 at λ_max 205, 224, 283, 304, and 443, verifying the above inference. The ¹H NMR (400 MHz, DMSO–d₆, Fig. S14 in Supporting information) and ¹H–¹H COSY spectrum (Fig. 3) revealed the presence of two ABX systems (δ_H 7.90 (d, J = 8.6 Hz, 1H), 7.53 (d, J = 8.7 Hz, 1H), 7.11 (d, J = 2.4 Hz, 1H), 6.92 (d, J = 2.2 Hz, 1H), 6.77 (dd, J = 8.7, 2.2 Hz, 1H), 6.73 (dd, J = 8.6, 2.4 Hz, 1H)). The ¹H NMR spectrum (600 MHz, DMSO–d₆, Table 1) showed the presence of two O-methyls (δ_H 3.85 (s, 3H), 3.84 (s, 3H)) and one methyl (δ_H 2.84 (s, 3H)), as well as one active hydrogen δ_H 11.78 (s, 1H) for the indole N-H of β-carboline. The ¹³C NMR spectrum (Fig. S15 in Supporting information) displayed methoxy (δ_c 55.13, 55.30) and its linked carbon signals (δ_c 158.93, 157.64), further illustrating the ABX system based on the structural features of Peganum harmala alkaloids. In addition, there existed one methylene δ_H 4.92 and the ¹H–¹H COSY spectrum (Fig. S16 in Supporting information) showed that δ_H 4.92 was coupled to 3.26, which was interfered with by the water peak in ¹H NMR. The HSQC spectrum (Fig. S17 in Supporting information) gave a carbon signal (δ_C 19.1) connected to the interfered signal (δ_H 3.26). The hydrogens δ_H 4.92 were presumed to be the H-3 of the parent nucleus of harmaline and N-2 atom of the pyridine ring had a stronger electron-absorbing capacity than the nitrogen atom of harmaline. The overall presumption was that there existed two β-carboline parent nuclei (one of which was a harmaline parent nucleus) and that the nitrogen atom at the indole site from the other β-carboline parent nuclei was not connected by any active hydrogen. The HMBC spectrum (Fig. 3) showed that the 9-position N-H of Part a correlated with C-10, C-11, C-12, and C-13, respectively, suggesting an indole ring structure. H-3 correlated with C-1 and C-10 and H-4 correlated with C-10, C-11, and C-12, revealing a structure of a harmaline parent nucleus. For Part b, because of the N-H disappearance of the indole ring, a large change in the chemical shift of N atom at the indole-site double bond to the neighboring C atom occurred compared to Part a (153.6 for C-13′ (139.2 for C-13 in Part a) and 152.8 for C-10′ (126.6 for C-10 in Part a)), seen from Fig. 2. H-4′ correlated with C-1 and C-10, which could connect Part a and Part b. Part a was a harmaline-like structure while Part b was the structure of pegaharmine K in a published article [12]. Since the lone electron pair of N atom at position 2 was involved in the whole conjugation system, which made this N atom enhance electron-absorbing capacity for C-3, with the chemical shift of H-3 reaching δ_H 4.92 compared with harmaline's H-3 value that was 3.67. The structural formula of the compound was shown in Fig. 2. Because of the presence of the long conjugate system, the compound solution displayed a strong UV absorption. The trivial name was given as peganumium B.

  Compound 3 was obtained as a white crystal (methanol). Its molecular formula was determined to be C₁₆H₁₉N₂⁺O₂Cl⁻ with 9 indices of hydrogen deficiency by HR-ESI-MS at m/z 271.1442 [M]⁺ (calcd. 271.1441). The ¹H NMR (400 MHz, DMSO–d₆, Table 1) showed the presence of an ABX system (δ_H 8.23 (d, J = 8.9 Hz, 1H), 7.17 (d, J = 2.2 Hz, 1H), 7.06 (dd, J = 8.9, 2.2 Hz, 1H) and of typical H-3/H-4 signals (δ_H 8.53 (d, J = 6.6 Hz, 1H) 8.34 (d, J = 6.6 Hz, 1H)) in the harmine parent nucleus, with ¹H–¹H COSY (Fig. 3) assisting in validating the above relationship. Compared to the NMR of harmine [14], there were three more hydrogen (δ_H 6.03 (s, 2H), 3.69 (q, J = 7.0 Hz, 2H), 1.24 (t, J = 7.0 Hz, 3H)) signals and three more carbon signals (δ_C 87.2, 66.8, 15.1). The HSQC spectrum (Fig. S24 in Supporting information) gave the corresponding hydrocarbon signals. The HMBC spectrum (Fig. 3) showed the most critical correlation of H-15 and C-1/C-13, indicating that the side chain was attached at 2-position N atom. In ¹H NMR spectrum of CDCl₃ (Fig. S22 in Supporting information) and DMSO–d₆, the presence of active hydrogen at the N-9 position of the indole ring was observed, with chemical shifts of 14.10 and 13.23, respectively. Since the total alkaloids were treated with hydrochloric acid after extraction and the NMR spectrum did not show any other anions containing carbon and hydrogen, as well as the fact that a saturated aqueous solution of the compound produced a white precipitate when titrated with silver nitrate solution, the anionic part was determined to be Cl⁻. The structural formula of the compound was shown in Fig. 2. The trivial name was given as peganumium C.

  The biosynthetic pathways of the four compounds above were also speculated (Section Ⅰ in Supporting information). The cytotoxic activities of compounds 1–3 against four human cancer cell lines (HCT116, MGC803, A549, and PANC-1) were evaluated using the CCK-8 method with harmine and cisplatin as the positive control (Table 2). Compounds 1–3 exhibited better in vitro antiproliferative activity. Compound 2, in particular, had 24-h IC₅₀ of 4.34 ± 0.24, 5.77 ± 0.30, 8.05 ± 0.26, and 2.16 ± 0.18 µmol/L against HCT116, MGC803, A549, and PANC-1 cells, respectively. Moreover, its activity was superior to that of the positive drugs used. In summary, compound 2 (peganumium B) performed the best antiproliferative activity in vitro.

  Table 2

  

  Table 2.  IC₅₀ (µmol/L) of the compounds on four cancer cell lines.

  DownLoad: CSV

  Compd.	HCT116	MGC803	A549	PANC-1
  1	7.73 ± 0.36	10.13 ± 0.46	39.93 ± 3.42	–
  2	4.34 ± 0.24	5.77 ± 0.30	8.05 ± 0.26	2.16 ± 0.18
  3	16.01 ± 0.76	26.81 ± 2.98	–	–
  Harmine	5.78 ± 0.67	16.82 ± 1.11	20.19 ± 4.13	10.56 ± 1.58
  Cisplatin	6.63 ± 0.22	13.56 ± 1.39	22.72 ± 0.91	–
  -: Undetermined.

  Utilizing a bromodeoxyuridine (BrdU) incorporation assay, we observed a marked suppression in the proliferation of PANC-1 cells following treatment with varying concentrations of peganumium B (2 and 4 µmol/L) for 48 h (Fig. 4A). The transwell assay was observed that invasive capabilities of PANC-1 cells were not affected by 1 µmol/L of peganumium B but was repressed with 2 µmol/L of peganumium B, compared with the control group (Fig. 4B).

  Figure 4

  

  Figure 4.  The results of biological assays for peganumium B. (A) PANC-1 cells were collected and stained with BrdU and 4′, 6-diamidino-2-phenylindole (DAPI) and analyzed via a fluorescence microscopy. Scale bar: 50 µm. (B) The transwell assay on PANC-1 cells. Scale bar: 100 µm. (C) Differential metabolites on MGC803 cells. For the horizontal coordinate, "0" was the control group and "1" was the dosing group. (D) Screening of differential metabolite pathways. (E) Effects of the drug on mitochondrial morphology and content of nematodes. Data were presented as means ± standard deviation (SD) of independent tests (n = 3 (A, B), n = 6 (C) and n = 15 (E)). **P < 0.01, ***P < 0.001, ****P < 0.0001.

  DownLoad: Full-Size Img PowerPoint

  Metabolomics was a valuable tool used to analyze mechanisms of biological activity [15]. In the present study, the mechanism related to the in vitro antiproliferative effect of peganumium B on MGC803 cells was investigated by ¹H NMR metabolomics. Based on the results of the multivariate analysis and peak area changes, ten differential metabolites, including tyrosine, glycine, lysine, creatine, leucine, succinate, adenosine diphosphate (ADP), uridine diphosphate glucose (UDP-glucose), nicotinamide adenine dinucleotide (NAD⁺), and taurine, were screened before and after dosing (Fig. 4C). Then these differential metabolites were introduced into the Metaboanalyst 6.0 software for further analysis (Supporting information). The results showed that the antiproliferative effect of peganumium B on MGC803 cells at 5 µmol/L concentration was associated with biosynthesis and metabolic pathways of some amino acids, taurine and hypotaurine metabolism, and nicotinate and nicotinamide metabolism (Fig. 4D). In addition, the downregulation of NAD⁺ [16] and ADP was likely to affect mitochondrial function, which played a key role in mitochondrial respiration and would be explored as follows.

  Based on the metabolite analysis, the effect of the drug on mitochondrial morphology was evaluated in vivo based on Caenorhabditis elegans (C. elegans) model. We chose a C. elegans strain expressing red fluorescent protein (RFP) targeted to the outer mitochondrial membrane in body-wall muscle cells. After drug treatment (10 µmol/L), there was no significant change in network connectivity, indicated by the area/perimeter ratio, but a slight reduction in mitochondrial content (Fig. 4E). The latter was speculated to be associated with the decrease in NAD⁺ [17]. Overall, our study has not only enriched the chemical composition of Peganum harmala L. and discovered two new skeletons with very long conjugation systems, but also identified a compound peganumium B with excellent in vitro anticancer activity.

  Declaration of competing interest

  The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  CRediT authorship contribution statement

  Yongjian Liu: Writing – original draft, Methodology, Investigation. Cen Liu: Writing – original draft, Methodology, Investigation, Data curation. Haitao Guo: Writing – review & editing, Data curation. Jinchai Qi: Writing – review & editing, Validation. Heng Chen: Writing – review & editing. Yuping Yang: Writing – review & editing. Tao Ma: Writing – review & editing, Validation, Supervision, Resources, Methodology, Formal analysis, Conceptualization. Yonggang Liu: Validation, Supervision, Resources, Project administration, Funding acquisition, Conceptualization.

  Acknowledgment

  Financial support from Beijing Natural Science Foundation (No. 7232283) is gratefully acknowledged.

  Supplementary materials

  Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.cclet.2024.110558.

  
  
• 1. [1]

     F.A. Khan, A. Maalik, Z. Iqbal, et al., Eur. J. Pharmacol. 721 (2013) 391–394.

  2. [2]

     C.H. Wang, J. Liu, L.M. Zheng, Chin. Pharm. J. 37 (2002) 53–57.

  3. [3]

     S. Li, X. Cheng, C. Wang, J. Ethnopharmacol. 203 (2017) 127–162.

  4. [4]

     Z. Zhu, S. Zhao, C. Wang, Molecules 27 (2022) 4161. doi: 10.3390/molecules27134161

  5. [5]

     Q. Zhang, Y.H. Zan, H.G. Yang, et al., Phytochemistry 197 (2022) 113107.

  6. [6]

     K.B. Wang, Y.T. Di, Y. Bao, et al., Org. Lett. 16 (2014) 4028–4031. doi: 10.1021/ol501856v

  7. [7]

     Y. d. Yang, X. m. Cheng, W. Liu, et al., RSC Adv. 6 (2016) 15976–15987.

  8. [8]

     K.B. Wang, S.G. Li, X.Y. Huang, et al., Eur. J. Org. Chem. 2017 (2017) 1876–1879. doi: 10.1002/ejoc.201700137

  9. [9]

     Y. Yang, X. Cheng, W. Liu, et al., J. Ethnopharmacol. 168 (2015) 279–286. doi: 10.1109/CCBD.2015.57

  10. [10]

      K.B. Wang, X. Hu, S.G. Li, et al., Fitoterapia 125 (2018) 155–160.

  11. [11]

      K.B. Wang, D.H. Li, P. Hu, et al., Org. Lett. 18 (2016) 3398–3401. doi: 10.1021/acs.orglett.6b01560

  12. [12]

      K.B. Wang, D.H. Li, Y. Bao, et al., J. Nat. Prod. 80 (2017) 551–559.

  13. [13]

      S.G. Li, K.B. Wang, C. Gong, et al., Bioorg. Med. Chem. Lett. 28 (2018) 103–106.

  14. [14]

      Y.J. Liu, H. Liu, L. H S, et al., China Tradit. Herb. Drugs 55 (2024) 705–710.

  15. [15]

      A. Tan, X.X. Tan, Chin. Chem. Lett. 35 (2024) 109276.

  16. [16]

      J.Y. Zhu, A. Ouyang, Z.L. Shen, et al., Chin. Chem. Lett. 33 (2022) 1907–1912.

  17. [17]

      K.M. Ralto, E.P. Rhee, S.M. Parikh, Nat. Rev. Nephrol. 16 (2020) 99–111. doi: 10.1038/s41581-019-0216-6

• 

  Figure 1  Structure of compounds harmaline and harmine.

  下载: 全尺寸图片 幻灯片
  

  Figure 2  Structure and numbering of compounds 1–3.

  下载: 全尺寸图片 幻灯片
  

  Figure 3  Key ¹H–¹H COSY and HMBC correlations of compounds 1–3.

  下载: 全尺寸图片 幻灯片
  

  Figure 4  The results of biological assays for peganumium B. (A) PANC-1 cells were collected and stained with BrdU and 4′, 6-diamidino-2-phenylindole (DAPI) and analyzed via a fluorescence microscopy. Scale bar: 50 µm. (B) The transwell assay on PANC-1 cells. Scale bar: 100 µm. (C) Differential metabolites on MGC803 cells. For the horizontal coordinate, "0" was the control group and "1" was the dosing group. (D) Screening of differential metabolite pathways. (E) Effects of the drug on mitochondrial morphology and content of nematodes. Data were presented as means ± standard deviation (SD) of independent tests (n = 3 (A, B), n = 6 (C) and n = 15 (E)). **P < 0.01, ***P < 0.001, ****P < 0.0001.

  下载: 全尺寸图片 幻灯片

  Table 1.  ¹H and ¹³C NMR data of compounds 1–3 (ppm).

  1 (600/150 MHz, DMSO–d6)				2 (600/150 MHz, DMSO–d6)				3 (400/100 MHz, CD3OD)
  No.	δH (J in Hz)	δC		No.	δH (J in Hz)	δC		No.	δH (J in Hz)	δC
  1		142.7 C		1		132.6 C		1		140.0 C
  2		N atom		2		N atom		2		N atom
  3	4.66 t (7.3)	48.8 CH2		3	4.92 t (7.2)	44.3 CH2		3	8.53 d (6.6)	134.5 CH
  4	3.32 overlap	19.0 CH2		4	3.26 overlap	19.1 CH2		4	8.34 d (6.6)	114.7 CH
  5	7.64 d (8.7)	120.6 CH		5	7.54 d (8.6)	120.1 CH		5	8.23 d (8.9)	125.5 CH
  6	6.84 dd (8.7, 2.2)	111.9 CH		6	6.77 dd (8.7, 2.2)	110.6 CH		6	7.06 dd (8.9, 2.2)	114.9 CH
  7		159.3 C		7		157.6 C		7		165.8 C
  8	6.96 d (2.2)	93.8 CH		8	6.92 d (2.2)	94.5 CH		8	7.17 d (2.2)	95.1 CH
  9	12.01	NH		9	11.78 s	NH		9a	14.10 s (CDCl3)	NH
  10		124.9 C		10		126.6 C		10		136.9 C
  11		117.6 C		11		112.9 C		11		134.7 C
  12		119.1 C		12		120.1 C		12		115.2 C
  13		140.8 C		13		139.2 C		13		148.5 C
  14	3.84 s	55.6 CH3		14	3.84 s	55.1 CH3		14	3.16 s	14.7 CH3
  15	8.36 s	113.2 CH		1′		141.6 C		15	6.03 s	87.2 CH2
  16		145.2 C		4′	7.20 s	104.9 CH		16	3.69 q (7.0)	66.8 CH2
  17	7.87 d (2.6)	119.1 CH		5′	7.94 d (8.6)	122.6 CH		17	1.24 t (7.0)	15.1 CH3
  18		154.0 C		6′	6.76 dd (8.6, 2.4)	107.6 CH		18	3.99 s	56.4 CH3
  19	2.87 s	21.1 CH3		7′		158.9 C
  20	3.63 s	51.4 CH3		8′	7.11 d (2.4)	100.1 CH
  1′		157.3 C		9′		N atom
  2′	7.62 m	NH		10′		152.8 C
  3′	3.26 overlap	41.4 CH2		11′		120.4 C
  4′	3.26 overlap	25.9 CH2		12′		117.6 C
  5′	7.59 d (8.8)	121.4 CH		13′		153.6 C
  6′	6.82 dd (8.7, 2.2)	111.4 CH		14′	3.85 s	55.3 CH3
  7′		158.8 CH		15′	2.84 s	19.6 CH3
  8′	6.89 d (2.2)	93.4 CH
  9′	11.83	NH
  10′		127.4 C
  11′		118.9 C
  12′		123.3 C
  13′		139.0 C
  14′	3.83 s	55.6 CH3
  a The chemical shift of the N-9 active hydrogen in CDCl3 was 14.10, while in DMSO–d6 it was 13.23.

  下载: 导出CSV

  Table 2.  IC₅₀ (µmol/L) of the compounds on four cancer cell lines.

  Compd.	HCT116	MGC803	A549	PANC-1
  1	7.73 ± 0.36	10.13 ± 0.46	39.93 ± 3.42	–
  2	4.34 ± 0.24	5.77 ± 0.30	8.05 ± 0.26	2.16 ± 0.18
  3	16.01 ± 0.76	26.81 ± 2.98	–	–
  Harmine	5.78 ± 0.67	16.82 ± 1.11	20.19 ± 4.13	10.56 ± 1.58
  Cisplatin	6.63 ± 0.22	13.56 ± 1.39	22.72 ± 0.91	–
  -: Undetermined.

  下载: 导出CSV
•